SCL · Stepan Co - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.33B | $2.18B | $2.33B | $2.77B | $2.35B | $1.87B |
| Cost of Revenue | $2.06B | $1.91B | $2.05B | $2.35B | $1.95B | $1.49B |
| Gross Profit | $269.89M | $272.21M | $277.60M | $427.07M | $395.81M | $383.61M |
| R&D | $34.80M | $33.54M | $35.73M | $40.90M | $38.78M | $36.00M |
| SG&A | $90.79M | $98.28M | $93.20M | $102.18M | $92.91M | $87.36M |
| Total Operating Expenses | $200.99M | $201.73M | $204.98M | $218.45M | $221.68M | $210.88M |
| D&A | $126.04M | $112.20M | $105.34M | $94.65M | $90.88M | $81.86M |
| Operating Income | $78.55M | $70.48M | $58.61M | $207.34M | $170.78M | $171.52M |
| Interest Expense | $30.77M | $33.03M | $29.36M | $17.85M | $10.14M | $9.86M |
| Income Tax | $13.01M | $10.07M | $8.19M | $41.55M | $34.64M | $43.41M |
| Net Income | $46.90M | $50.37M | $40.20M | $147.15M | $137.80M | $126.77M |
| EPS - Basic | $2.05 | $2.21 | $1.77 | $6.46 | $6.01 | $5.52 |
| EPS - Diluted | $2.05 | $2.20 | $1.75 | $6.38 | $5.92 | $5.45 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $132.69M | $99.67M | $129.82M | $173.75M | $159.19M | $349.94M |
| Accounts Receivable | $387.96M | $388.03M | $422.05M | $436.91M | $419.54M | $301.32M |
| Inventory | $298.83M | $288.72M | $265.56M | $402.53M | $305.54M | $218.78M |
| Accounts Payable | $261.72M | $258.79M | $233.03M | $375.73M | $323.36M | $236.75M |
| Current Assets | $858.96M | $810.43M | $851.88M | $1.04B | $913.37M | $905.65M |
| Total Assets | $2.36B | $2.30B | $2.36B | $2.43B | $2.07B | $1.75B |
| Current Liabilities | $666.49M | $669.03M | $607.87M | $670.65M | $500.48M | $416.55M |
| Long-term Debt | $340.98M | $332.63M | $401.25M | $455.03M | $322.86M | $160.81M |
| Total Liabilities | - | - | - | - | - | - |
| Stockholders' Equity | $1.24B | $1.17B | $1.22B | $1.17B | $1.07B | $986.69M |
| Retained Earnings | $1.29B | $1.27B | $1.26B | $1.25B | $1.13B | $1.02B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $147.88M | $162.05M | $174.88M | $160.76M | $72.14M | $235.22M |
| Investing Cash Flow | ($89.05M) | ($116.94M) | ($258.67M) | ($308.09M) | ($376.83M) | ($139.03M) |
| Financing Cash Flow | ($35.44M) | ($64.52M) | $33.28M | $166.21M | $117.33M | ($64.93M) |
| CapEx | $122.51M | $122.78M | $260.33M | $301.55M | $194.48M | $125.79M |
| Free Cash Flow | $25.37M | $39.28M | ($85.46M) | ($140.79M) | ($122.35M) | $109.42M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 11.6% | 12.5% | 11.9% | 15.4% | 16.9% | 20.5% |
| Operating margin | 3.4% | 3.2% | 2.5% | 7.5% | 7.3% | 9.2% |
| EBITDA margin | 8.8% | 8.4% | 7.0% | 10.9% | 11.2% | 13.6% |
| Net margin | 2.0% | 2.3% | 1.7% | 5.3% | 5.9% | 6.8% |
| Free cash flow margin | 1.1% | 1.8% | -3.7% | -5.1% | -5.2% | 5.9% |
| FCF / Net income | 0.54 | 0.78 | -2.13 | -0.96 | -0.89 | 0.86 |
| R&D / Revenue | 1.5% | 1.5% | 1.5% | 1.5% | 1.7% | 1.9% |
| SG&A / Revenue | 3.9% | 4.5% | 4.0% | 3.7% | 4.0% | 4.7% |
| Effective tax rate | 21.7% | 16.7% | 16.9% | 22.0% | 20.1% | 25.5% |
| Return on assets | 2.0% | 2.2% | 1.7% | 6.0% | 6.7% | 7.2% |
| Return on equity | 3.8% | 4.3% | 3.3% | 12.6% | 12.8% | 12.8% |
| Return on invested capital | 3.9% | 3.9% | 3.0% | 10.0% | 9.8% | 11.1% |
| Liquidity | ||||||
| Current ratio | 1.29 | 1.21 | 1.40 | 1.56 | 1.82 | 2.17 |
| Quick ratio | 0.84 | 0.78 | 0.96 | 0.96 | 1.21 | 1.65 |
| Cash ratio | 0.20 | 0.15 | 0.21 | 0.26 | 0.32 | 0.84 |
| Leverage | ||||||
| Debt / Equity | 0.27 | 0.28 | 0.33 | 0.39 | 0.30 | 0.16 |
| Debt / Assets | 0.14 | 0.14 | 0.17 | 0.19 | 0.16 | 0.09 |
| Debt / EBITDA | 1.67 | 1.82 | 2.45 | 1.51 | 1.23 | 0.63 |
| Interest coverage | 2.6x | 2.1x | 2.0x | 11.6x | 16.8x | 17.4x |
| Equity multiplier | 1.90 | 1.97 | 1.94 | 2.09 | 1.92 | 1.78 |
| Liabilities / Assets | - | - | - | - | - | - |
| Efficiency | ||||||
| Asset turnover | 0.99 | 0.95 | 0.98 | 1.14 | 1.14 | 1.07 |
| Inventory turnover | 6.90 | 6.61 | 7.71 | 5.83 | 6.38 | 6.79 |
| Days sales outstanding | 61d | 65d | 66d | 58d | 65d | 59d |
| Days inventory outstanding | 53d | 55d | 47d | 63d | 57d | 54d |
| Days payable outstanding | 46d | 50d | 42d | 58d | 61d | 58d |
| Cash conversion cycle | 67d | 71d | 72d | 62d | 62d | 54d |
| Valuation | ||||||
| P / E | 23.1x | 29.4x | 54.0x | 16.7x | 21.0x | 21.9x |
| P / B | 0.9x | 1.3x | 1.8x | 2.1x | 2.7x | 2.8x |
| P / S | 0.5x | 0.7x | 0.9x | 0.9x | 1.2x | 1.5x |
| EV / EBITDA | 6.3x | 9.4x | 14.9x | 9.1x | 11.7x | 10.2x |
| Growth | ||||||
| Revenue growth (YoY) | 7.0% | -6.3% | -16.1% | 18.2% | 25.5% | 0.6% |
| Revenue CAGR (3y) | -5.6% | -2.4% | 7.5% | 14.3% | 9.9% | -1.0% |
| Revenue CAGR (5y) | 4.5% | 3.2% | 5.7% | 7.6% | 5.8% | 1.0% |
| Gross profit growth (YoY) | -0.9% | -1.9% | -35.0% | 7.9% | 3.2% | 12.9% |
| Operating income growth (YoY) | 11.4% | 20.2% | -71.7% | 21.4% | -0.4% | 34.8% |
| Net income growth (YoY) | -6.9% | 25.3% | -72.7% | 6.8% | 8.7% | 22.9% |
| EPS growth (YoY) | -6.8% | 25.7% | -72.6% | 7.8% | 8.6% | 23.3% |
| EPS CAGR (3y) | -31.5% | -28.1% | -31.5% | 13.0% | 7.0% | 11.6% |
| EPS CAGR (5y) | -17.8% | -13.0% | -18.4% | 10.2% | 9.7% | 10.4% |
| FCF growth (YoY) | -35.4% | - | 39.3% | -15.1% | - | -3.0% |
| FCF CAGR (5y) | -25.3% | -19.0% | - | - | - | 11.3% |
| Book value growth (YoY) | 6.3% | -3.8% | 4.3% | 8.6% | 8.9% | 10.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$2.33B totalSurfactants$1.67B · 71.4%
Polymers$584.48M · 25.1%
Specialty Products$81.65M · 3.5%
Geographic
$4.00B totalUS$1.30B · 32.5%
North America$954.05M · 23.9%
Latin America$357.05M · 8.9%
Europe$306.99M · 7.7%
FR$211.45M · 5.3%
All Other Countries$181.57M · 4.5%
GB$169.91M · 4.2%
MX$164.01M · 4.1%
BR$156.24M · 3.9%
PL$148.94M · 3.7%
Asia$47.88M · 1.2%
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
6/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✗Long-term debt decreased
- ✓Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Comparing STEPAN CO against the 5 most active filers in the same SIC group.
Dividends
$1.57/share trailing 12 months · +2.6% YoY
| Ex-date | Per share |
|---|---|
| Jun 1, 2026 | $0.3950 |
| Mar 2, 2026 | $0.3950 |
| Nov 28, 2025 | $0.3950 |
| Aug 29, 2025 | $0.3850 |
| May 30, 2025 | $0.3850 |
| Mar 3, 2025 | $0.3850 |
| Nov 29, 2024 | $0.3850 |
| Aug 30, 2024 | $0.3750 |
| May 31, 2024 | $0.3750 |
| Feb 29, 2024 | $0.3750 |
| Nov 29, 2023 | $0.3750 |
| Aug 30, 2023 | $0.3650 |
| May 30, 2023 | $0.3650 |
| Mar 2, 2023 | $0.3650 |
| Nov 29, 2022 | $0.3650 |
| Aug 30, 2022 | $0.3350 |
| May 27, 2022 | $0.3350 |
| Mar 3, 2022 | $0.3350 |
| Nov 29, 2021 | $0.3350 |
| Aug 30, 2021 | $0.3050 |
| May 27, 2021 | $0.3050 |
| Mar 4, 2021 | $0.3050 |
| Nov 27, 2020 | $0.3050 |
| Aug 28, 2020 | $0.2750 |